EA200700246A1 - Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора - Google Patents

Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора

Info

Publication number
EA200700246A1
EA200700246A1 EA200700246A EA200700246A EA200700246A1 EA 200700246 A1 EA200700246 A1 EA 200700246A1 EA 200700246 A EA200700246 A EA 200700246A EA 200700246 A EA200700246 A EA 200700246A EA 200700246 A1 EA200700246 A1 EA 200700246A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrazol
modulator
cannabinoid receptor
tricyclic derivatives
regioisomers
Prior art date
Application number
EA200700246A
Other languages
English (en)
Other versions
EA011307B1 (ru
Inventor
Брадж Бхушан Лохрай
Видья Бхушан Лохрай
Бриджеш Сривастава
Original Assignee
Кадила Хелзкэр Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кадила Хелзкэр Лимитед filed Critical Кадила Хелзкэр Лимитед
Publication of EA200700246A1 publication Critical patent/EA200700246A1/ru
Publication of EA011307B1 publication Critical patent/EA011307B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Настоящее изобретение относится к новым соединениям общей формулы (I), их региоизомерам, таутомерным формам, новым промежуточным соединениям, используемым в их синтезе. Настоящее изобретение также относится к способу получения соединений общей формулы (I), их региоизомеров, их таутомерных форм, их фармацевтически приемлемых солей, содержащих их фармацевтических композиций и используемых в их синтезе новых промежуточных соединений.
EA200700246A 2004-07-12 2005-07-08 Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора EA011307B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN745MU2004 2004-07-12
PCT/IN2005/000237 WO2006025069A2 (en) 2004-07-12 2005-07-08 Tricyclic pyrazole derivatives as cannabinoid receptor modulators

Publications (2)

Publication Number Publication Date
EA200700246A1 true EA200700246A1 (ru) 2007-08-31
EA011307B1 EA011307B1 (ru) 2009-02-27

Family

ID=35636669

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700246A EA011307B1 (ru) 2004-07-12 2005-07-08 Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора

Country Status (20)

Country Link
US (2) US8030345B2 (ru)
EP (2) EP2343302A1 (ru)
JP (1) JP2008505965A (ru)
KR (1) KR20070041717A (ru)
CN (1) CN101014605A (ru)
AP (1) AP2228A (ru)
AU (1) AU2005278781B2 (ru)
BR (1) BRPI0513104A (ru)
CA (1) CA2586011C (ru)
EA (1) EA011307B1 (ru)
EC (1) ECSP077167A (ru)
GE (1) GEP20094682B (ru)
IL (1) IL180637A0 (ru)
MX (1) MX2007000491A (ru)
NO (1) NO20070299L (ru)
NZ (2) NZ552670A (ru)
TN (1) TNSN07006A1 (ru)
UA (1) UA88910C2 (ru)
WO (1) WO2006025069A2 (ru)
ZA (1) ZA200700162B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101014605A (zh) * 2004-07-12 2007-08-08 卡地拉健康护理有限公司 用作大麻素受体调节物的三环吡唑衍生物
KR20200008045A (ko) 2009-08-28 2020-01-22 아레나 파마슈티칼스, 인크. 칸나비노이드 수용체 조절제
US20140206649A1 (en) 2011-02-25 2014-07-24 Jayant Thatte Cannabinoid receptor modulators
DK3395812T3 (da) 2011-02-25 2022-11-28 Arena Pharm Inc Krystallinske former og fremgangsmåder til fremstilling af kondenserede azacykler (cannabinoid-receptor-modulatorer)
WO2012116277A1 (en) 2011-02-25 2012-08-30 Arena Pharmaceuticals, Inc. Cannabinoid receptor modulators
US10351576B2 (en) * 2015-04-30 2019-07-16 Novartis Ag Fused tricyclic pyrazole derivatives useful for farnesoid X receptors
CA3010615C (en) 2016-01-14 2024-02-20 Beth Israel Deaconess Medical Center, Inc. Mast-cell modulators and uses thereof
US20210052597A1 (en) * 2018-01-29 2021-02-25 Cadila Healthcare Limited Heterocyclic compounds useful as antibacterial agents

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3260721A (en) * 1962-04-10 1966-07-12 American Cyanamid Co Heterocyclic derivatives of yohimbe alkaloids
DK7779A (da) * 1978-01-16 1979-07-17 Sandoz Ag Fremgangsmaade til fremstilling af pnenicilliner eller cephalosporiner
EP0122952B1 (en) 1983-04-22 1987-10-28 Mitsubishi Rayon Co., Ltd. Apparatus for measuring gas partial pressure in living body
FR2713225B1 (fr) 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
FR2714057B1 (fr) 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
US5547975A (en) * 1994-09-20 1996-08-20 Talley; John J. Benzopyranopyrazolyl derivatives for the treatment of inflammation
FR2741621B1 (fr) 1995-11-23 1998-02-13 Sanofi Sa Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2742148B1 (fr) 1995-12-08 1999-10-22 Sanofi Sa Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2758723B1 (fr) 1997-01-28 1999-04-23 Sanofi Sa Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
FR2761266B1 (fr) 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
FR2789079B3 (fr) 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
FR2800372B1 (fr) * 1999-11-03 2001-12-07 Sanofi Synthelabo Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant
FR2800375B1 (fr) * 1999-11-03 2004-07-23 Sanofi Synthelabo Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
FR2804604B1 (fr) 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
FR2809621B1 (fr) 2000-05-12 2002-09-06 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles comme antidiarrheiques
FR2816938B1 (fr) 2000-11-22 2003-01-03 Sanofi Synthelabo Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
CA2457922A1 (en) 2001-08-31 2003-03-13 University Of Connecticut Novel pyrazole analogs acting on cannabinoid receptors
WO2003026647A1 (en) 2001-09-21 2003-04-03 Solvay Pharmaceuticals B.V. Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
CA2442245C (en) 2001-09-21 2010-03-30 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
TWI231757B (en) 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US6509367B1 (en) 2001-09-22 2003-01-21 Virginia Commonwealth University Pyrazole cannabinoid agonist and antagonists
CA2476665A1 (en) * 2002-02-19 2003-08-28 Pharmacia Corporation Tricyclic pyrazole derivatives for the treatment of inflammation
ITMI20041033A1 (it) * 2004-05-24 2004-08-24 Neuroscienze S C A R L Composti farmaceutici
CN101014605A (zh) * 2004-07-12 2007-08-08 卡地拉健康护理有限公司 用作大麻素受体调节物的三环吡唑衍生物

Also Published As

Publication number Publication date
IL180637A0 (en) 2007-06-03
ECSP077167A (es) 2007-05-30
NO20070299L (no) 2007-03-26
EP2343302A1 (en) 2011-07-13
CA2586011C (en) 2011-07-19
AP2228A (en) 2011-04-01
JP2008505965A (ja) 2008-02-28
NZ552670A (en) 2010-02-26
WO2006025069A2 (en) 2006-03-09
US20100273791A1 (en) 2010-10-28
TNSN07006A1 (en) 2008-06-02
AP2007003880A0 (en) 2007-02-28
UA88910C2 (ru) 2009-12-10
CN101014605A (zh) 2007-08-08
AU2005278781A1 (en) 2006-03-09
ZA200700162B (en) 2009-09-30
US8030345B2 (en) 2011-10-04
GEP20094682B (en) 2009-05-10
MX2007000491A (es) 2007-03-28
KR20070041717A (ko) 2007-04-19
EA011307B1 (ru) 2009-02-27
WO2006025069A3 (en) 2006-04-27
EP1781668A2 (en) 2007-05-09
CA2586011A1 (en) 2006-03-09
US20080051386A1 (en) 2008-02-28
BRPI0513104A (pt) 2008-04-29
NZ580387A (en) 2011-06-30
WO2006025069A8 (en) 2007-03-15
AU2005278781B2 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
EA200700246A1 (ru) Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора
MY143834A (en) Thrombin receptor antagonists
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
ATE402697T1 (de) 1,3,5-trisubstituierte 4,5-dihydro-1h-pyrazol- derivative mit cb1-antagonistischer aktivität
MY136959A (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
NO20064579L (no) Bifenylforbindelser anvendelige som muskariniske receptorantagonister
WO2009116074A3 (en) Substituted benzimidazoles as cannabinoid modulator
CY1108880T1 (el) Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200870074A1 (ru) Производные 4,5-дигидро-(1н)-пиразола в качестве модуляторов каннабиноидного рецептора св1
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DK1893589T3 (da) Substituerede N-benzo[d]isoxazol-3-yl-amin-derivater som inhibitorer af mGluR5-, serotonin-(5-HT) og noradrenalinreceptorer og deres anvendelse til fremstilling af lægemidler
NO20062249L (no) 1H-imidazolderivater som cannabionidreseptor modulatorer
EA200600060A1 (ru) Аминосульфонилзамещенные 4-(аминометил) пиперидинбензамиды в качестве 5нт-антагонистов
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
MXPA05013256A (es) Derivados de 1-(alquilaminoalquil-pirolidin-/piperidinil) -2,2-difenilacetamida como antagonistas de receptores muscarinicos.
EA200970426A1 (ru) Селективный агонист tr-бета 1
WO2005009104A3 (en) Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
ATE549331T1 (de) Sulfoximinderivate asp38-map-kinase-inhibitoren
EA201071227A1 (ru) (5r)-1,5-диарил-4,5-дигидро-1h-пиразол-3-карбоксамидиновые производные, обладающие св1-антагонистической активностью
UA92736C2 (ru) Производные 1н-имидазола как модуляторы рецепторов канабиноидов св2

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU